Biogen recently bolstered its pipeline with a potential $1.8 billion acquisition of Human Immunology Biosciences, following ...

Despite a surge in the financial markets, multiple big pharma companies have announced hundreds or even thousands of cuts.

Building on last year’s potential $7 billion partnership with Flagship Pioneering, Pfizer and Flagship-founded ProFound ...

Teva Pharmaceuticals lost its patent row with Amneal Pharmaceuticals on Monday as a New Jersey court ruled that some of ...

Sen. Bernie Sanders (I-Vt.), chair of the Senate health committee, has proposed issuing a subpoena to Novo Nordisk President ...

The BIOSECURE Act, which seeks to protect U.S. national security from Chinese biotech companies, will not be part of the ...

The House Select Committee asks the FBI for a briefing on GenScript’s links to China, fueling the challenge facing public ...

Seeking to target the lucrative obesity market, Merck is focusing its R&D efforts on next-generation GLP-1 therapies that offer additional benefits beyond weight loss, according to company executives.

This week, an FDA adcomm unanimously voted for the approval of Eli Lilly’s anti-amyloid antibody as thousands of layoffs continue to rattle the industry.

GSK reported that a plaintiff voluntarily dropped her Zantac case against the company and that it is in the process of ...

Seeking to carve out its own niche in the obesity space, Syntis Bio launched on Tuesday to develop an oral weight-loss ...

Stada announced Tuesday it has secured European rights from Alvotech to a clinical-stage biosimilar of Amgen’s blockbuster ...